You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

1 Reports indicate that a shortage of GLP-1 drugs began in late 2022 and has continued well ... complications as well as both ...

That means it could be dosed without considering meal timings, which is a consideration with some drugs in the oral GLP-1 class. For example, Novo Nordisk's oral formulation of semaglutide for dia ...

As Ozempic and other GLP-1 drugs explode in popularity ... Social media influencers, often unregulated, showcase examples of rapid weight loss, sometimes using images of individuals who wouldn ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

For example, during the event, AstraZeneca shared promising early data for its oral GLP-1 candidate, AZD5004, and told Fierce ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

For example, Roberts has found that even moving some runs from ... loss while training for something extreme like a marathon.

Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...